Since olaparib has opposed effects on these lncRNAs, upregulating MAMDC2-AS1, but downregulating SNHG15 and LINC01135, we could say that these results do not show a clear trend towards a benefit from olaparib treatment.
← all excerpts
The PARP Inhibitor Olaparib Modulates the Transcriptional Regulatory Networks of Long Non-Coding RNAs during Vasculogenic Mimicry.
1
—
—